Tuesday May 12, 2020
12 May 2020 – Posting of Annual Report and Notice of AGM
Destiny Pharma plc (“Destiny Pharma” or “the Company”) Posting of Annual Report and Accounts, and Notice of AGM Brighton, United Kingdom – 12 May 2020 – Destiny Pharma (AIM: DEST), […]
Thursday May 7, 2020
07 May 2020 – Director of Preclinical Development as panel member for KTN Antimicr...
Daniel Hynes, Director of Preclinical Development will be sitting on the panel of a Knowledge Transfer Network webinar on May 20th discussing the outcomes of the 2019 AMR Expert Mission […]
Wednesday May 6, 2020
06 May 2020 – FT article highlights Coronavirus lessons for the fight against supe...
Destiny Pharma targets infection prevention through its novel XF drugs and has the potential to be one of the leaders in the battle against superbugs. This FT article says COVID-19 […]
Monday May 4, 2020